Rhabdomyosarcoma is a rare cancer arising in skeletal muscle that typically impacts children and young adults. It is a worldwide challenge in child health as treatment outcomes for metastatic and recurrent disease still pose a major concern for both basic and clinical scientists. The treatment strategies for rhabdomyosarcoma include multi-agent chemotherapies after surgical resection with or without ionization radiotherapy. In this comprehensive review, we first provide a detailed clinical understanding of rhabdomyosarcoma including its classification and subtypes, diagnosis, and treatment strategies. Later, we focus on chemotherapy strategies for this childhood sarcoma and discuss the impact of three mechanisms that are involved in the chemotherapy response including apoptosis, macro-autophagy, and the unfolded protein response. Finally, we discuss in vivo mouse and zebrafish models and in vitro three-dimensional bioengineering models of rhabdomyosarcoma to screen future therapeutic approaches and promote muscle regeneration.
Currently, macroporous hydrogels have been receiving attention in wastewater treatment due to their unique structures. As a natural polymer, alginate is used to remove cationic dyes due to its sustainable features such as abundance, low cost, processability, and being environmentally friendly. Herein, alginate/montmorillonite composite macroporous hydrogels (cryogels) with high porosity, mechanical elasticity, and high adsorption yield for methylene blue (MB) were generated by the one-step cryogelation technique. These cryogels were synthesized by adding montmorillonite into gel precursor, followed by chemical cross-linking employing carbodiimide chemistry in a frozen state. The as-prepared adsorbents were analyzed by FT-IR, SEM, gel fraction, swelling, uniaxial compression, and MB adsorption tests. The results indicated that alginate/montmorillonite cryogels exhibited high gelation yield (up to 80%), colossal water uptake capacity, elasticity, and effective dye adsorption capacity (93.7%). Maximum adsorption capacity against MB was 559.94 mg g−1 by linear regression of Langmuir model onto experimental data. The Pseudo-Second-Order model was fitted better onto kinetic data compared to the Pseudo-First-Order model. Improved porosity and mechanical elasticity yielding enhanced dye removal capacity make them highly potential alternative adsorbents compared to available alginate/montmorillonite materials for MB removal.
20 October 2021 in Free Radical Biology and Medicine
Rhabdomyosarcoma is a rare cancer arising in skeletal muscle that typically impacts children and young adults. It is a worldwide challenge in child health as treatment outcomes for metastatic and recurrent disease still pose a major concern for both basic and clinical scientists. The treatment strategies for rhabdomyosarcoma include multi-agent chemotherapies after surgical resection with or without ionization radiotherapy. In this comprehensive review, we first provide a detailed clinical understanding of rhabdomyosarcoma including its classification and subtypes, diagnosis, and treatment strategies. Later we focus on chemotherapy strategies for this childhood sarcoma and discuss the impact of three mechanisms that are involved in chemotherapy response including apoptosis, macro-autophagy, and the unfolded protein response. Finally, we discuss in vivo mouse and zebrafish models, and in vitro 3-dimensional bioengineering models of Rhabdomyosarcoma to screen future therapeutic approaches and promote muscle regeneration.